About
Metabolic OSA
News
Careers
Contact Us

About
Metabolic OSA
News
Careers
Contact Us

MedPharm collaborates with Mosanna to develop new drug to tackle Metabolic Obstructive Sleep Apnea

•September 21, 2022

•Jonathan Talbot

Read the full announcement here

Previous PostMosanna Therapeutics Announces a Seed Financing Round to Advance Development of MOS-118 to Treat Metabolic Obstructive Sleep ApneaNext PostMosanna to Participate in BIO-EUROPE 2022 Partnering Forum

Improving the lives of patients with metabolic obstructive sleep apnea

Contact Us

Mosanna Therapeutics AG
Grellingerstrasse 91
4052 Basel
Switzerland

info@mosanna.com

© 2022 Mosanna Therapeutics AG